Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2729812
下载链接
链接失效反馈官方服务：
资源简介：
A first-in-human study to evaluate the safety, tolerability and maximum tolerated dose (MTD) and establish the recommended phase 2 dose (RP2D) of BPI-442096, a SHP2 inhibitor, in patients with advanced solid tumors.
创建时间：
2022-06-15
